𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab tolerability in Crohn’s disease patients

✍ Scribed by Gary R. Lichtenstein; Greg Keenan; Mary Glenn Vreeland; Donny M. Chen

Book ID
119391832
Publisher
Nature Publishing Group
Year
2001
Tongue
English
Weight
27 KB
Volume
96
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of concurrent na
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab
✍ Bruce E. Sands; Richard Kozarek; Jack Spainhour; Charles F. Barish; Scott Becker 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

## Background: Natalizumab, a humanized monoclonal igg(4) antibody to alpha4 integrin, was investigated as a treatment of active crohn's disease (cd). the safety of natalizumab given in combination with infliximab has not previously been studied. ## Methods: Seventy-nine adult patients with activ